Company: LDDD
Filing Date: 2025-09-26
Form Type: 10-K
Source: 0001213900-25-091988
Chunk: 131

Company: Longduoduo Co Ltd
Filing Date: 2025-09-26
Form: 10-K
Item: Item 1A
Chunk 131
---
,171,564  
     7,216,493  
     (3,044,929) 
     (42)%

    Total operating expenses 
     3,618,885  
     5,190,352  
     (1,571,467) 
     (30)%
  
    Income from operations 
     552,679  
     2,026,141  
     (1,473,462) 
     (73)%
  
    Other income (expense) 
     161,849  
     (139,656) 
     301,505  
     (216)%
  
    Income before income taxes 
     714,528  
     1,886,485  
     (1,171,957) 
     (62)%
  
    Income taxes 
     222,268  
     523,207  
     (300,939) 
     (58)%
  
    Net income 
     492,260  
     1,363,278  
     (871,018) 
     (64)%

During
the year ended June 30, 2025, our total revenue was $4,262,663, of which $120,866 was attributable to the sale of healthcare services,
primarily derived from sales of “Immunological Ozonated Autohemotherapy”, “Meridian-regulating and Consciousness-restoring
Iatrotechnics”, “Assay”, “PRP” and other healthcare services. The remaining $4,141,797 of revenue was attributable
to commissions earned by the Company from its service as sales agent for Honghai. In June of 2023, the Company began to engage in the
sales agent business and focused on the sales of preventive healthcare solutions administered by Honghai, with whom we have a Sales Agency
Agreement. As of June 30, 2025, we operate through five entities: Longduoduo Health Technology, Tianju, Qingguo, Rongbin and Chengheng,
which are established in Huhhot, Ulanqab, Huhhot, Baotou and Ordos, respectively, which include four of the largest cities in Inner Mongolia,
China.

Annual
to annual revenue fell by 42% as compared with the operating revenue of $7,389,842 for the year